Publication Summary

DUCRAY

Cathepsin S, a new pruritus biomarker in clinical dandruff/ seborrhoeic dermatitis evaluation

C. Viode, O. Lejeune, V. Turlier, A. Rouquier, C. Casas, V. Mengeaud, D. Redoules, A-M. Schmitt
Experimental Dermatology
2014

Objective

Evaluation of the role of cathepsin S in pruritus associated with seborrheic dermatitis.

Cathepsin S is a cysteine protease that activates PAR-2 (proteinase-activated receptor 2) receptors

  

Methodology

N= 11 adult patients with seborrheic dermatitis of the scalp, compared with a control group (n=10)

Assessment of PAR2 and histamine protein expression to compare the results of two distinct pruritus-inducing pathways

 

Evaluation criteria

Global clinical score for severity of seborrheic dermatitis scored by the investigator (Squire score from 0 to 80)

Intensity of pruritus scored by patients (4-point scale)

 

Results

  • Cathepsin S levels in patients with seborrheic dermatitis 5 times higher than in the control group 
  • Positive correlation between cathepsin S levels, PAR-2 receptor expression and pruritus intensity

 

Conclusion

Cathepsin S can be used as a biomarker to quantify pruritus sensations and contribute to the quantitative evaluation of the efficacy of seborrheic dermatitis treatments

Our other publications on this subject